MicroPort® has always been committed of constantly being at the innovative forefront to deliver best and affordable solutions that save life and improve quality of life.
Every 18 seconds, somewhere around the world, MicroPort® transforms a patient's life by bringing life-saving treatments or quality-improving care, or gives new hope of starting a family.
Global presence in 12 countries and regions
3,000 + employees worldwide
200 R&D staff in China
Over 300 employees in Marketing and Sales
MicroPort® is contributing to a better world through its life-saving medical therapies and quality-improving care devices being used in patients every 18 seconds.
Jul 21, 2016
New Delhi, India –On July 14, Firehawk® Rapamycin Target Eluting Coronary Stent System ("Firehawk®"), in-house developed by Shanghai MicroPort Medical (Group) Co ("MicroPort®")... More
MicroPort Orthopedics, headquartered in Arlington, TN., is a global medical device company specializing ... More
MicroPort Endovascular primary focus is on the development, manufacture, and marketing of the ... More
MicroPort EP primary focus is on the development, manufacture, and marketing of minimally ... More